Roger Crystal News Today

While some harm reduction advocates want to see OPVEE as commercially available as Narcan, others say the medication is so strong that it’s cruel for the patient.

Kroger announced Friday that it agreed to pay $1.2 billion to settle the majority of claims that it exacerbated the opioid crisis in the United States.

MindMed’s (NASDAQ: MNMD) heated proxy battle over R&D strategy might finally be coming to an end.

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), today announced that, based upon a preliminary vote assessment, shareholders have elected all six of the Company’s nominees – CEO ...

Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. GryskaHighlights Significant Positive Momentum to Advance R&D Pipeline and Enhance Shareholder ValueDiscloses FCM MM HOLDINGS’ Intent to Take Control of the Board Through Nomination of...

Presents Highly Qualified Slate of Director Nominees, Including Five Incumbent Board Members and New Independent Candidate David W. Gryska Highlights Significant Positive Momentum to Advance... | June 19, 2023

The FDA has accepted for Priority Review the New Drug Application for OPNT003 (nasal nalmefene) for the treatment of opioid overdose.

The FDA has accepted for Priority Review the New Drug Application for OPNT003 (nasal nalmefene) for the treatment of opioid overdose.

Oklahoma announced new settlements totaling $226.1 million with three pharmacy chains and a drug manufacturer over the opioid epidemic on Wednesday.

FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.